AIHW Board AIHW senior staff Annual report Capability statement Collaboration AIHW corporate plan 2016–17 to 2019–20 Customer care charter FOI - freedom of information Indexed list of files Nous review Organisation chart Presentations Privacy of data Public Interest Disclosure Tenders
By category Ageing, disability & carers Families & children Hospitals Housing & homelessness Indigenous Australians Population groups Risk factors, diseases & death Services, workforce & spending
By subject Adoptions Aged care Ageing Alcohol & other drugs Arthritis & musculoskeletal conditions Asthma Australia's health Australia's welfare Burden of disease Cancer Cardiovascular disease Child health, development & wellbeing Child protection Children's services Chronic diseases
Chronic kidney disease Chronic respiratory conditions COPD Deaths Dementia Dental & oral health Diabetes Disability Expenditure Eye health Food & nutrition Health indicators Health performance Homelessness Hospitals Housing assistance Indigenous Australians Injury Life expectancy
Male health Mental health Mothers & babies Overweight & obesity Palliative care Population health Primary health care Prisoner health Risk factors Rural health Safety & quality of health care Veterans' health Workforce Youth health & wellbeing Youth justice
In other sections Data Publications Contact AIHW
Publications CatalogueOrdering publicationsForthcoming publications Online reports Subscribe to release notices
By subject Adoptions Aged care Ageing Alcohol & other drugs AIHW annual reports Arthritis & musculoskeletal conditions Asthma Australia's health Australia's welfare Burden of disease Cancer Cardiovascular disease Child health, development & wellbeing Child protection Children's services Chronic diseases Chronic kidney disease
Chronic respiratory conditions Corporate publications Data linkage Data standards Deaths Dental & oral health Diabetes Disability Expenditure Eye health Food & nutrition General practice Health indicators Health performance Homelessness Hospitals Housing assistance Indigenous Australians Indigenous housing
Injury Life expectancy Male health Mental health services Mothers & babies Overweight & obesity Palliative care Population health Primary health carePrisoner health Risk factors Rural health Safety & quality of health care Veterans' health Workforce Youth health & wellbeing Youth justice
In other sections Subjects Data Contact AIHW
About AIHW data METeOR—metadata online registry Data by subject AIHW data collections Customised data analysis request Data governance framework Data linking Data standards GovHack Privacy of data Accessing Australian Government health and welfare data
By subjectAboriginal and Torres Strait Islander Health Performance Framework Adoptions Aged care Alcohol and other drugs Alcohol data sources Body weight data sources Cancer Children's headline indicators (CHI) Child protection Data sources for monitoring health conditionsDeaths Diabetes Disability
Expenditure FHBH - Fixing houses for better health General Record of Incidence of Mortality (GRIM) books Height and weight data sources Hospitals Indigenous Australians International collaboration Maternity Information Matrix (MIM) Medical indemnity Mental health Mortality Over Regions and Time (MORT) books National Aged Care Data Clearinghouse
National core maternity indicators (NCMI) National framework for protecting Australia’s children (NFPAC) National indicator catalogue National Youth Information Framework (NYIF) Perinatal data Primary Health Network (PHN) Specialist Homelessness Services (SHS) Tobacco data sources Workforce
In other sections Subjects Publications Contact AIHW
AACR ACFADD AHSAC AIHW Board AIHW Ethics Committee AODTS NMDS WG CKDMAC CMAG CVDMAC HEAC
IGIHM JJ RIG MHISSC NAGATSIHID NCSIMG NDDWG NDIMG NHISSC NIAG NIRAPIMG NMDDNMDS
NMHPSC NOPSAD NPDDC NPHEP NPHIC PCDWG PDWG PHIDG PHIG REDWG Workforce committees
Education worksheets Infographics What's in the pipeline Subscribe to education notices Other educational links
Resources by subject All Latest Ageing Australia's health Australia's welfare Carers
Children & youth Disability Disease Drugs
Health Health prevention Indigenous Australians Injury
In other sections Subjects Data Publications Contact AIHW
Job vacancies How to apply for a position at the AIHW Conditions of employment Benefits of working for the AIHW Temporary employment register Occupational Training Program Contact the People Unit Graduates
AIHW Access magazine Media releases Subscribe to release notices Embargoed access to AIHW material Media contacts
You are here:
Applicant: Cancer Institute NSWApproval valid until: 01 July 2021
This project seeks to develop a de-identified dataset containing data from several state and territory data sources, including: ACT Cancer Registry; NSW Cancer Registry; ACT and NSW Hospital Admissions; ACT and NSW Emergency Department Data Collections; BreastScreen NSW.
Data will also be drawn from the following Commonwealth data sources: National Death Index (NDI); Medicare Benefits Schedule (MBS); Pharmaceutical Benefits Schedule (PBS).
The final, linked dataset will be used for various purposes, including:
Findings will contribute to improved clinical outcomes for ACT and NSW cancer patients.
Applicant: Queensland HealthApproval valid until: 30 June 2018
The Australian Health Ministers’ Advisory Council (AHMAC), at the 2013 Closing the Gap Strategic Discussion, highlighted disparities in the incidence of cardiovascular complications and treatment utilisation between Indigenous and non-Indigenous individuals as a major health priority. The Better Cardiac Care for Aboriginal and Torres Strait Islander People project was established to address these disparities.
The objective of this study is to assess the continuum of cardiac care against clinical guidelines and best practice standards. The cohort consists of patients, of all ages, who were first hospitalised in Queensland, during the period 2010/2011 to 2014/2015, with a diagnosis of Ischaemic Heart Disease (IHD), Congestive Heart Failure (CHF), Stroke or Acute Rheumatic Fever/Rheumatic Heart Disease (ARF/RHD).
The study cohort will be linked with the National Death Index (NDI); Medicare Benefits Schedule (MBS); Pharmaceutical Benefits Schedule (PBS).
Findings will inform health service planning to improve the availability and accessibility of treatment for Indigenous individuals with cardiovascular complications.
Applicant: University of New South WalesApproval valid until: 01 July 2018
Australia’s rapidly increasing ageing population, particularly Centenarians, continues to place significant demands on the health system. This project—The Sydney Centenarian Study—a longitudinal investigation, seeks to identify genetic and environmental factors that contribute to quality of life among Sydney residents aged 95 years and over.
The objectives of this study include:
Data will be linked with the National Death Index (NDI).
Findings will inform health policy and initiatives designed to improve and maintain quality of life among elderly individuals.
The Older Australian Twins Study (OATS) is a comprehensive study of ageing in 600 twins, older than 64 years, recruited through the Australian Twin Registry. A major focus of this investigation is cognitive decline, and establishing the role of genetic and environmental factors.
The OATS cohort will be linked with the National Death Index (NDI) to identify deceased individuals and their cause/s of death.
OATS findings will contribute to a greater understanding of the precursors of cognitive decline. This information can be used to inform early interventions and initiatives that may delay, or even prevent, the onset of cognitive deterioration.
Applicant: Southern Metropolitan Health/University of Western AustraliaApproval valid until: 31 December 2017
Among women, breast cancer is the most common type of cancer diagnosed. The majority of cases are hormone receptor positive. This study seeks to identify factors that may be linked to improved outcomes for women with hormone receptor positive breast cancer.
A study cohort, consisting of approximately 1,900 women registered on the Royal Perth Hospital Breast Unit Database, between 1994 and 2011, will be linked with the Pharmaceutical Benefits Schedule (PBS) to assess treatment adherence and concomitant prescription medication use.
Findings will contribute to the development of initiatives and interventions, designed to optimise outcomes.
The Sydney Memory and Ageing Study (SMAS) was initiated to investigate the prevalence of and progression of cognitive decline in elderly individuals.
The SMAS study cohort will be linked with the National Death Index (NDI) to identify deceased individuals, their age at death and cause/s of death.
Findings will inform policies and initiatives designed to enhance elderly Australians’ quality of life.
Applicant: University of Notre DameApproval valid until: 28 February 2023
An objective of this study is to establish a database of individuals with pulmonary hypertension—a common, yet under-diagnosed condition characterised by high blood pressure between the heart and lungs. Both retrospective and prospective data will be collected from digital echo laboratories across Australia.
The Echo database will be linked with the National Death Index (NDI) as part of this study.
The database will facilitate the identification of individuals with pulmonary hypertension, and those at risk of this condition. This should allow health professionals to reduce the burden of disease, and enhance quality of life.
Applicant: Royal Adelaide HospitalApproval valid until: 01 March 2019
This study investigates post-surgery outcomes among patients with Cushing’s Disease—a condition characterised by excessive release of adrenocorticotropic hormone from the anterior pituitary gland.
A cohort will be drawn from national and state-based hospital record data. It will be linked with the National Death Index (NDI) to:
Findings will inform policies and practices designed to improve the management of Cushing’s Disease, and patients’ quality of life.
Applicant: NSW TreasuryApproval valid until: 30 June 2021
This study seeks to examine life trajectories of young people, leaving out-of-home care (OOHC).
The study scope is individuals aged between 14 and 18 years, who exited OOHC from 1996/97 until the most recent financial year for which data are available.
The OOHC cohort will be linked with several Commonwealth data sources, including Medicare Benefits Schedule (MBS), Pharmaceutical Benefits Schedule (PBS), Centrelink data, Vocational Education and Training, and Higher Education support.
Findings will facilitate the development of policy directions and services for young people after leaving OOHC.
Applicant: Cancer Council VictoriaApproval valid until: 01 April 2026
The Melbourne Collaborative Cohort Study (MCCS) was a large, population-based investigation that prospectively examined known and putative risk factors for cancer and other common chronic disease.
This linkage project will link data from the Melbourne Collaborative Cohort Study (MCCS) with the National Death Index (NDI) and the Australian Cancer Database (ACD).
Findings will contribute to those of the MCCS by further consolidating existing initiatives and interventions that attempt to reduce the burden of disease posed by cancer and other chronic illness, and enhance quality of life.
Applicant: The George Institute for Global HealthApproval valid until: 01 May 2024
The original SHARP study investigated the effectiveness of cholesterol-lowering treatment among pre-dialysis and dialysis patients. A key objective was to examine the time taken to reach the first occurrence of a major atherosclerotic event. The cholesterol-lowering medication reduced this time by 17 per cent. Despite this finding, gaps still exist in research on reducing the burden of morbidity and mortality associated with kidney disease.
The SHARP-ER study extends the follow-up of the original SHARP study by an additional five years. Using patient visits, telephone contact, hospital record review and linkage to national data registries, this extended follow-up will provide data regarding the long-term effects for patients with chronic kidney disease and end-stage kidney disease.
This project will link the SHARP cohort with the National Death Index (NDI) to obtain mortality data for those who have died since the final SHARP study visit in 2010 until the end of the SHARP-ER study (2015).
Findings in this study will identify the long-term effects of cholesterol-lowering treatment on chronic kidney disease. Health practitioners can use this information to improve medical care for patients with chronic kidney disease, thereby minimising the burden of disease, and enhancing quality of life.
Applicant: Cancer Council VictoriaApproval valid until: 01 June 2020
This project investigates whether variables of inequality—socioeconomic status and distance to services—contribute to the incidence of, and survival from, colorectal cancer in Victoria.
Data from the Victorian Cancer Registry (VCR) will be linked with the National Bowel Cancer Screening Program (NBCSP).
Findings will lead to a greater understanding of factors that influence the variation in both risk and outcomes of colorectal cancer and help to better target interventions, thereby reducing the burden of disease.
Applicant: The Royal Children’s Hospital, MelbourneApproval valid until: 01 January 2020
This project is a retrospective review of outcomes following heart surgery performed on approximately 2,000 children, in particular surgery for atrioventricular septal defects (AVSD). The sample was drawn from paediatric centres in Melbourne, Sydney, Perth, Brisbane and Auckland, of children who had surgery from 1975 onwards.
This project investigates the long-term outcomes of AVSD surgery. It will also study risk factors for patient mortality, while attempting to highlight surgical techniques and interventions associated with improved survival.
The study cohort will be linked with the National Death Index (NDI) to obtain mortality data for deceased patients in the cohort.
Health practitioners can use study findings to enhance survival rates following AVSD surgery.
Applicant: The Doherty InstituteApproval valid until: 31 March 2019
Viral hepatitis is now the leading cause of liver cancer, and liver transplants. The aim of this study is to identify individuals most at risk of living with, and suffering adverse outcomes from, viral hepatitis. Another objective is to determine the level of clinical engagement and treatment uptake among those diagnosed with this debilitating condition, and to establish the impact of service access in preventing complications arising from infection.
The study cohort consists of people in Victoria who were the subjects of notification for hepatitis B or C between 1997 and 2014 (approximately 90,000). This cohort will be sourced from the Victorian Public Health Events Surveillance System, and linked with the following data sources: Victorian Admitted Episodes Dataset (VAED); Victorian Emergency Minimum Dataset (VEMD); Victorian Cancer Registry (VCR); National Death Index (NDI); Medicare Benefits Schedule (MBS); Pharmaceutical Benefits Schedule (PBS)
Findings will contribute to the early identification of individuals at risk of viral hepatitis and assist health practitioners in implementing interventions to minimise this risk, as well as adverse outcomes that may result following onset of the condition.
Applicant: Royal Melbourne Hospital and The University of MelbourneApproval valid until: 01 July 2020
An aortic valve replacement (AVR) is the most commonly used technique to treat aortic valve disease, and prevent progression to heart failure and, in some cases, death. Prostheses, such as bioprostheses and mechanical valves, have historically been used as replacement valves. Bioprostheses have a functional capacity of approximately 15 years. Mechanical valves, on the other hand, despite being durable, require lifelong anticoagulation with medications such as Warfarin. Both bleeding and clotting complications have thus been linked to AVR with mechanical valves.
The Ross procedure—a more complex surgical technique—is an alternative approach that uses an individual’s pulmonary valve to replace the aortic valve; a homograft is fitted to replace the pulmonary valve. A prominent advantage of this procedure is that it results in an aortic valve that is living and capable of remodelling, and thus overcomes many of the limitations associated with both bioprosthetic and mechanical valves.
The objective of this study is to ascertain which of the available options for AVR—bioprostheses, mechanical valves, and the Ross procedure—are associated with the most optimal long-term survival outcomes.
A study cohort will be linked with the National Death Index (NDI) to obtain mortality data, which will be used as an index of long-term survival outcome.
The study findings could potentially improve survival for people with aortic valve disease.
Applicant: Murdoch Children’s Research Institute (MCRI)Approval valid until: 30 June 2018
A large body of research has investigated microbiological and immunological links between viruses and the development of Type I diabetes. Conversely, little is known about whether early vaccination has any impact on the incidence of diabetes in young children.
In Australia, the oral rotavirus vaccine (ORV) was introduced to the routine National Immunisation Program (NIP) for all infants born from 01 May 2007. As an extension of the NIP, a project was undertaken to ascertain whether early infant vaccination against the rotavirus had any impact on the incidence of diabetes in young children. This project sought to examine whether the incidence of Type I diabetes in young Australian children would have decreased in the five years following the introduction of the vaccine.
The present investigation, a retrospective case-control study, will link data from the National Diabetes Services Scheme (NDSS), between 01 July 2002 and 01 July 2012, with the Australian Childhood Immunisation Register (ACIR).Findings will establish whether rotavirus exposure is either a risk factor for, or a protective factor against, the onset of Type I diabetes in infant children, and help to reduce the burden of this disease among infants and their families.
Applicant: Princess Alexandra HospitalApproval valid until: 30 December 2017
This study assesses the efficacy of mammographic screening, among Queensland women.
It has the following objectives:
A study cohort will be obtained from the Queensland Oncology Repository (QOR), which comprises data from various sources, including the Queensland Cancer Registry and Deaths. The scope of the study cohort will be women, who were eligible for mammographic screening in 2000, drawn from the Queensland Electoral Commission.
Data from the study cohort will be linked with the Medicare Benefits Schedule (MBS) to establish attendance at breast cancer screening, and utilisation of related services, for women in the study cohort.
Findings will yield important information about the efficacy of mammographic screening in identifying women at risk of breast cancer, and those with existing tumours. This information can be used to progressively reduce rates of mortality associated with breast cancer among women.
Applicant: Murdoch Childrens Research Institute Approval valid until: 01 November 2023
The Victorian Cerebral Palsy Register (VCPR) collects and compiles data about Victorian cerebral palsy patients.
This study has the following objectives:
VCPR data will be linked with the National Death Index to identify deceased patients.
Findings will further contribute to the existing body of knowledge about mortality, and causes of mortality, among cerebral palsy patients. This will assist healthcare professionals to improve the care of cerebral palsy patients.
Applicant: Edith Cowan UniversityApproval valid until: 22 December 2017
This study investigates the effect of correctional education on re-imprisonment rates, welfare dependency, and employment outcomes. Another objective is to examine whether correctional education reduces the risk of premature mortality.
A prisoner and ex-prisoner cohort will be linked with the National Death Index.
Results will have implications for reducing re-offending (and re-imprisonment) through enhancing ex-prisoners' assimilation into the community.
Applicant: Garvan Institute of Medical ResearchApproval valid until: 03 September 2021
Prostate cancer is the second leading cause of mortality among Australian men. Healthcare professionals have sought to gain a better understanding of the underlying molecular mechanisms.
This study aims to compile a large tissue resource, and related database, to provide the foundation for further investigation of the genetic basis of prostate cancer. Specific study objectives include:
The study investigators seek mortality data to update patient records. A cohort will be linked with the National Death Index.
Study findings will enable healthcare professionals to target interventions more effectively, reducing mortality and improving quality of life.
Applicant: University of NewcastleApproval valid until: 01 February 2021
The growing incidence of cardiovascular disease has prompted healthcare professionals and policymakers to develop initiatives that reduce cardiovascular-related morbidity and mortality. One such initiative-the Australian Study for the Prevention through Immunisation of Cardiovascular Events (AUSPICE), a multi-centre clinical trial-investigates the effectiveness of the pneumococcal vaccine in reducing cardiovascular events.
As part of the AUSPICE study, data will be linked with the National Death Index, Australian Cancer Database, Medicare Benefits Schedule and Pharmaceutical Benefits Schedule.
The potential of the pneumococcal vaccine to protect against cardiovascular disease is of public health significance. Findings will pose implications for reducing cardiovascular-related mortality.
Applicant: Griffith UniversityApproval valid until: 31 December 2019
This study investigates mortality among young people who have had contact with the Queensland Youth Justice System. In particular, it will examine the incidence and causes of premature deaths. Specific objectives include:
A cohort containing individuals who had contact with the Queensland youth justice system between 1993 and 2014 will be linked with the National Death Index.
Study findings will inform policy and assist targeted interventions to reduce premature mortality among juvenile offenders. Furthermore, because young, Indigenous Australians are over-represented in the youth justice system, results will also assist policymakers and healthcare professionals to reduce the gap in life expectancy between Indigenous and non-Indigenous Australians.
Applicant: Cancer Council VictoriaApproval valid until: 31 December 2017
Young adult cancer patients typically display low survival rates. Researchers have attributed this poor prognosis to a multitude of factors, including patient, disease and healthcare factors. It should be noted that the delivery of young adult cancer services is often fragmented. Patients may receive treatment at either paediatric or adult facilities.
In response to growing mortality rates among young adult cancer patients, this study seeks to identify the modifiable health-system factors and practices that influence survival.
Data will be linked with the National Death Index.
Study findings will enable policymakers and healthcare professionals to improve survival rates for young adult cancer patients.
Applicant: University of New South WalesApproval valid until: 01 February 2018
This project is a population-based, case-control, family study of adults with gliomas-cancers of the brain or spine-and unaffected family members. It will examine the contribution of environmental, lifestyle and occupational factors, and genetic variables to the development of gliomas. This project will also investigate the relationship between these variables and survival rates.
As part of this project, a cohort of adult glioma patients, diagnosed between 2013 and 2016, and unaffected family members, will be linked with the National Death Index and the Australian Cancer Database.
Gliomas have poor prognoses. Furthermore, there have been no prior family-based, case-control studies of gliomas. Through identifying potential risk factors for the onset of gliomas, findings will enable researchers and healthcare professionals to enhance disease prognosis and, ideally, prevent disease onset.
Applicant: Sydney South West Area Health Service - LiverpoolApproval valid until: 31 December 2026
Liverpool Hospital, in New South Wales, Australia, implemented a multidisciplinary cardiac meeting in 2008 to promote long-term survival outcomes of high-risk, cardiac patients.
This project-a retrospective, observational study-examines post-cardiac surgery mortality rates at one, three, five, seven, and ten years.
The Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) maintain a database of cardiac surgical procedures, and outcomes in Australia, with data from 28 hospitals. This database will be linked with the National Death Index to obtain mortality data for patients who underwent cardiac surgery between 2008 and 2015.
Study findings will provide important information about survival outcomes following cardiac surgery. Healthcare professionals can use this information to improve the management of cardiac patients, thereby enhancing surgical prognoses.
Applicant: Flinders University Approval valid until: 31 December 2017
Motor vehicle accidents, either fatal or non-fatal, place a significant burden on the healthcare system, and impose substantial financial demands on insurance providers. Australia's road safety agencies have thus attempted to reduce the incidence of motor vehicle accidents through a multitude of safe-driving initiatives. For these agencies to continue to improve road safety, they require up-to-date, national data about motor vehicle accidents that result in either fatal or non-fatal injuries.
The purpose of this study is to inform road safety policies and initiatives through the provision of up-to-date, national data about motor vehicle accidents, and related mortality.
State and territory motor vehicle accident data, and hospital records will be linked with the National Death Index.
Study findings will contribute to the improvement of road safety, and reduced mortality by informing road safety initiatives and enhancing the effectiveness of existing measures.
Applicant: Baker IDI Heart and Diabetes Institute Approval valid until: 01 September 2017
The Baker IDI Heart and Diabetes Institute has maintained a database of various cardiovascular risk and protective factors for over 15,000 patients.
This project investigates the relationship between various cardiovascular risk factors and mortality-both cardiovascular-related mortality and non-cardiovascular-related mortality.
Healthcare professionals can utilise study findings to improve the detection of individuals at risk of cardiovascular events, reduce the incidence of such events by targeting risk factors, and prevent cardiovascular-related mortality.
Applicant: Princess Alexandra Hospital, Queensland Approval valid until: 10 July 2017
Systemic amyloidosis is a rare condition. It is characterised by abnormal protein deposits in organs and tissues, which can lead to organ dysfunction and, in severe cases, mortality. Due to the rarity of systemic amyloidosis, little is known about its epidemiology.
The purpose of this study is to establish the incidence and prevalence of systemic amyloidosis. Additional study objectives include:
Study data will be linked with the National Death Index.
Study findings will provide much-needed information about the incidence and prevalence of systemic amyloidosis. Healthcare professionals can use this information to improve detection and management.
Applicant: Monash UniversityApproval valid until: 31 December 2019
Chronic heart failure has been linked to poor quality of life and, in many cases, premature mortality. In response to the immense burden of disease posed by chronic heart failure, the Screen-HFL, a longitudinal study, was developed. This study examined the extent to which NT-proB-type Natriuretic Peptide (NT-proBNP), a blood-borne substance, was a risk factor for chronic heart failure.
The present study has the following objectives:
SCREEN-HF data will be linked with the National Death Index.
Findings will enhance the early detection of individuals at risk of chronic heart failure. Healthcare professionals can target interventions appropriately to improve quality of life and reduce premature mortality.
Applicant: University of Western AustraliaApproval valid until: 31 December 2022
A 2011 study found that the annual mortality rate among recently released Australian offenders was approximately 10 times higher than that of incarcerated offenders.
The present study will, for the first time, examine health-related predictors of mortality among ex-prisoners.
A study cohort will be linked with the National Death Index.
Findings will inform evidence-based interventions to reduce ex-prisoner mortality.
Applicant: Royal North Shore HospitalApproval valid until: 31 July 2021
This study investigates surgical outcomes among neck of femur fracture patients. A long-term objective is to predict risk of adverse outcomes. Researchers will use two online, peri-operative risk assessment tools-the NSQIP (National Surgical Quality Improvement Program, a US online risk calculator) and the SORT (Surgical Outcome Risk Tool, a UK-based instrument)-to meet this long-term objective. Researchers will also compare predicted morbidity and mortality with observed events.
A patient cohort will be linked with the National Death Index to obtain mortality data at 30-days post-surgery. Researchers will compare NDI mortality data with predicted mortality to establish the accuracy of the risk assessment tools.
Findings will inform the accuracy of the NSQIP and SORT. Findings will also facilitate the detection of patients at risk of post-operative complications. Healthcare professionals can target interventions to reduce the likelihood of post-surgical mortality, and other complications.
Applicant: Cancer Council VictoriaApproval valid until: 31 December 2026
The Australian Breakthrough Cancer (ABC) study, an ongoing prospective investigation, aims to predict an individual's risk of cancer. The study examines the interaction between lifestyle and genomic factors, including the identification of genes involved in cancer formation.
ABC study data will be linked with the National Death Index (NDI) and Australian Cancer Database (ACD). NDI data will provide important mortality information; ACD data will identify those diagnosed with cancer.
Findings will facilitate early detection of cancer risk, targeted interventions and screening, and reduced mortality.
Applicant: Prince Charles Hospital/University of QueenslandApproval valid until: 31 December 2017
Degenerative aortic valve stenosis (AS) is the most common form of valvular heart disease. In severe cases, it has been linked to premature mortality. Corrective surgery is the standard treatment for AS. This, however, may not be suitable for 25 to 50 per cent of cases, due to multiple co-morbidities. In these instances, health professionals can utilise an alternative intervention-Balloon Aortic Valvuloplasty (BAV)-as a palliative approach. BAV can also be utilised as a pre-treatment option for transcatheter aortic valve implantation (TAVI).
A paucity of research has examined the effectiveness of BAV. This study investigates the effectiveness of BAV as a palliative procedure, and its utility as a pre-treatment option for TAVI.
A BAV patient cohort will be linked with the National Death Index.
Findings will provide much-needed information about the effectiveness of BAV as a palliative procedure for patients with inoperable aortic stenosis.
Applicant: Diabetes Centre, Royal Prince Alfred HospitalApproval valid until: 01 June 2017
In recent years, adult obesity rates and, in particular, those in young adults have increased significantly. Obesity has been linked to adverse health outcomes-cardiovascular disease, type II diabetes and, in severe cases, mortality. Furthermore, type II diabetes is highly prevalent among young adults.
This study aims to identify clinical risk factors for mortality among young adult type II diabetes patients. Another objective is to determine whether these risk factors differ from those associated with mortality among adult type II diabetes patients, and type I diabetes patients.
In this study, the Royal Prince Alfred Hospital Diabetes Centre, in collaboration with the University of Sydney, wish to link their database-a register of over 31,000 patients-with the National Death Index.
Findings will enhance early identification of young adults at risk of type II diabetes. Healthcare professionals can target interventions to reduce adverse health complications, and improve quality of life.
Applicant: University of New South WalesApproval valid until: 20 January 2022
The HSA Biobank, an initiative of the South Eastern Sydney Local Health District and University of New South Wales, is an ongoing collection of tumour banking and health data. Approximately 2,500 participants from all cancer types have been recruited, with ongoing recruitment. Samples and data are usually made available to third party researchers for projects with approval from an accredited Human Research Ethics Committee.
HSA Biobank data will be linked with the National Death Index. This will enable researchers to examine important questions such as the association of specific clinical and molecular features of cancer on survival. Research of this nature improves the understanding of cancer aetiology, and markers of diagnosis and treatment outcomes.
Applicant: University of MelbourneApproval valid until: 01 December 2019
The Women's Healthy Ageing Project (WHAP) is a longitudinal, prospective study of the health and well-being of Australian women. The WHAP collects data about lifestyle, quality of life, social connectedness, and cognitive decline. A primary objective is to identify cardiovascular, cognitive and lifestyle risk factors for mortality. The WHAP initially followed a middle-aged cohort. These women are now aged over 70 years.
The WHAP cohort will be linked with the National Death Index to examine relationships between neurological functioning, lifestyle factors, cardiovascular disease, and mortality.
Findings will identify risk and protective factors for mortality. Healthcare professionals can utilise this information to promote healthy ageing among women.
Applicant: Department of Cardiology, Western Health, VictoriaApproval valid until: 30 November 2017
Heart failure is a significant health concern. It is a prominent cause of mortality for children and adults and, in particular, the elderly. Western Health in Victoria, Australia established a cardio-geriatric unit to meet the health care needs of elderly heart failure patients. Within this unit, under a multidisciplinary care model, a cardiologist and geriatrician review patients' cardiovascular functioning. Patients also access additional cardiology services.
A Western Health patient cohort will be linked with the National Death Index. This will enable researchers to evaluate the effectiveness of interventions in reducing mortality among elderly heart failure patients.
Applicant: Royal Victorian Eye and Ear HospitalApproval valid until: 31 December 2017
Floppy Eyelid Syndrome (FES) is a rare condition resulting in sticky discharge and watering from the eye(s), droopiness of the upper eyelid(s) and, in some instances, reduced vision due to corneal damage. FES is strongly associated with Obstructive Sleep Apnoea, a debilitating condition linked to reduced life expectancy.
There are no published studies investigating life expectancy among FES patients. This study investigates premature mortality, and life expectancy, among FES patients. Data will be linked with the National Death Index.
Findings will have implications for enhancing FES patients' quality of life.
Applicant: University of South AustraliaApproval valid until: 31 December 2025
Joint replacements are one of the most common elective procedures in Australia. The Australian Orthopaedic Association (AOA) maintains the National Joint Replacement Registry (NJRR). This registry contains information about joint replacement procedures undertaken, including surgical outcomes such as revision surgery, and mortality. The AOR, through the NJRR aims, as its key objective, to identify factors that contribute to both poor and successful prognoses following joint replacement surgery.
AIHW previously linked the NJRR with the National Death Index. This linkage provided important information about deceased NJRR individuals.
As part of the current linkage, the NJRR will be linked with the Medicare Benefits Schedule and Pharmaceutical Benefits Schedule. The AOA will also access hospital data from state linkage units. Findings will enable the AOA to monitor a wider range of surgical outcomes. This will enable healthcare professionals to target interventions, enhance surgical outcomes, and reduce mortality.
Applicant: Monash UniversityApproval valid until: 31 December 2019
Approximately 50,000 Australians suffer a stroke each year. STAND FIRM, a research initiative, was designed to assist General Practitioners to manage stroke-related risk factors, and reduce stroke prevalence. STAND FIRM has recruited 570 stroke patients, randomly allocated to receive either an individualised management plan or standard care.
The STAND FIRM cohort will be linked with the National Death Index, Medicare Benefits Schedule and Pharmaceutical Benefits Schedule to meet the following objectives:
Findings will enable healthcare professionals to improve the management of stroke patients, and reduce the associated burden of disease.